Bulgari: important support for research into a vaccine against Covid-19

Bulgari today announced the creation of the Bvlgari Virus Free Fund, a non-profit organisation that will fund cutting-edge institutions pursuing innovative research strategies for the remission and treatment of different types of viruses. In particular, the fund will support two main institutions: the Jenner Institute at Oxford University, a hub for researchers involved in the creation and development of several vaccines, and the Lazzaro Spallanzani National Institute for Infectious Diseases in Rome, already supported by the brand at the outbreak of the Covid-19 emergency, through the funding of a high-tech microscope.
In collaboration with the Jenner Institute, the Bvlgari Virus Free Fund will also offer two scholarships covering the four years of doctoral studies. These initiatives not only aim to support graduate students and post-doctoral researchers engaged in Covid-19 research, but also to support the establishment of the Bulgari Clinical Fund, a fund for the development and clinical testing of new therapies, drugs and vaccines that can combat Covid-19 and related coronavirus strains.
The Bvlgari Virus Free Fund was set up thanks to a significant donation from the brand, which will also give its customers the opportunity to make their contribution through voluntary donations, using a new innovative tool: the Aura blockchain network, which allows consumers to trace the history and authenticity of luxury goods. Applied also to fundraising, it will ensure total traceability of donations (the brand is at the forefront of numerous other charitable initiatives such as its collaboration with Save the Children).